1. Home
  2. AORT vs JBGS Comparison

AORT vs JBGS Comparison

Compare AORT & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AORT
  • JBGS
  • Stock Information
  • Founded
  • AORT 1984
  • JBGS 2016
  • Country
  • AORT United States
  • JBGS United States
  • Employees
  • AORT N/A
  • JBGS N/A
  • Industry
  • AORT Medical/Dental Instruments
  • JBGS Real Estate Investment Trusts
  • Sector
  • AORT Health Care
  • JBGS Real Estate
  • Exchange
  • AORT Nasdaq
  • JBGS Nasdaq
  • Market Cap
  • AORT 1.5B
  • JBGS 1.4B
  • IPO Year
  • AORT 1993
  • JBGS 2017
  • Fundamental
  • Price
  • AORT $32.14
  • JBGS $20.42
  • Analyst Decision
  • AORT Strong Buy
  • JBGS Sell
  • Analyst Count
  • AORT 5
  • JBGS 2
  • Target Price
  • AORT $32.40
  • JBGS $16.00
  • AVG Volume (30 Days)
  • AORT 300.1K
  • JBGS 1.0M
  • Earning Date
  • AORT 08-07-2025
  • JBGS 07-29-2025
  • Dividend Yield
  • AORT N/A
  • JBGS 3.40%
  • EPS Growth
  • AORT N/A
  • JBGS N/A
  • EPS
  • AORT N/A
  • JBGS N/A
  • Revenue
  • AORT $390,084,000.00
  • JBGS $513,301,000.00
  • Revenue This Year
  • AORT $12.20
  • JBGS N/A
  • Revenue Next Year
  • AORT $10.63
  • JBGS $2.20
  • P/E Ratio
  • AORT N/A
  • JBGS N/A
  • Revenue Growth
  • AORT 5.94
  • JBGS N/A
  • 52 Week Low
  • AORT $21.97
  • JBGS $13.28
  • 52 Week High
  • AORT $32.94
  • JBGS $22.45
  • Technical
  • Relative Strength Index (RSI)
  • AORT 61.18
  • JBGS 65.32
  • Support Level
  • AORT $30.27
  • JBGS $18.79
  • Resistance Level
  • AORT $32.16
  • JBGS $22.45
  • Average True Range (ATR)
  • AORT 0.76
  • JBGS 0.75
  • MACD
  • AORT 0.01
  • JBGS 0.15
  • Stochastic Oscillator
  • AORT 98.71
  • JBGS 55.09

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

About JBGS JBG SMITH Properties

JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party asset management and real estate services. It generates maximum revenue from the commercial segment.

Share on Social Networks: